DEVICE FOR REMOVING A GAS FROM AN AQUEOUS LIQUID
20230083534 · 2023-03-16
Inventors
Cpc classification
B01D19/0005
PERFORMING OPERATIONS; TRANSPORTING
B01D63/04
PERFORMING OPERATIONS; TRANSPORTING
A61K33/00
HUMAN NECESSITIES
A61K33/00
HUMAN NECESSITIES
A61K2300/00
HUMAN NECESSITIES
A61K2300/00
HUMAN NECESSITIES
A61P7/08
HUMAN NECESSITIES
International classification
A61M1/36
HUMAN NECESSITIES
Abstract
The invention relates to a device for removing a gas from an aqueous liquid, particularly a blood liquid, comprising a first compartment permeated by the aqueous liquid during operation of the device; a second compartment permeated by a purging gas during operation of the device, the first compartment and the second compartment being separated from each other by a semipermeable membrane; and a third compartment permeated by a liquid proton donor during operation of device, said proton donor being an organic or inorganic acid, the first compartment and the third compartment being separated from each other by a membrane permeable to ions, and the membrane permeable to ions comprising at least one cation conductor.
Claims
1. A device for removing a gas from an aqueous liquid, comprising: a first compartment permeated by a blood liquid, preferably blood, during operation of the device; a second compartment permeated by a purging gas during operation of the device, the first compartment and the second compartment being separated from each other by a semipermeable membrane; and a third compartment permeated by a liquid proton donor during operation of the device, said proton donor being an organic or inorganic acid, the first compartment and the third compartment being separated from each other by a membrane permeable to ions, the membrane permeable to ions comprising at least one cation conductor.
2. The device according to claim 1, the carbon dioxide dissolved in the blood liquid reacting with hydrogen ions of the proton donor and forming carbonic acid due to the interaction between the blood liquid and the liquid proton donor through the membrane permeable to ions, the hydrogen ions diffusing through the membrane permeable to ions out of the liquid proton donor into the blood liquid.
3. The device according to claim 1 or 2, the arising carbonic acid decomposing into water and carbon dioxide for transporting away by the purging gas of the second compartment.
4. The device according to any one of the claims 1 through 3, the second compartment comprising a plurality of lines, preferably hollow fibers, made of the semipermeable material.
5. The device according to any one of the claims 1 through 4, the third compartment comprising a plurality of lines, preferably hollow fibers, made of the membrane permeable to ions.
6. The device according to any one of the claims 1 through 5, the membrane permeable to ions comprising a cation and anion conductor.
7. The device according to any one of the claims 4 through 6 and referencing the claims 3 and 4, the lines of the second compartment and the lines of the third compartment being present in the first compartment, except for the inlets and outlets thereof.
8. The device according to any one of the claims 4 through 7 and referencing the claims 3 and 4, the lines of the second compartment and the lines of the third compartment always being separated from each other by a partial volume of the first compartment.
9. The device according to any one of the claims 4 through 8, the first compartment comprising an inlet and an outlet in order to guide the aqueous liquid through the first compartment, the inlet and the outlet being disposed such that a flow of blood through the first compartment can be adjusted during operation of the device.
10. A composition comprising a liquid proton donor and permeating the third compartment of a device according to any one of the claims 1 through 9 for use in a method for treating hypercapnia.
11. A use of a composition comprising a liquid proton donor and permeating the third compartment of a device according to any one of the claims 1 through 9 for treating hypercapnia.
12. The composition according to claim 10 or use according to claim 11, the liquid proton donor being a preferably non-toxic acid or comprising an acidic buffer solution.
13. The composition according to claim 10 or 12 or use according to claim 11 or 12, at least one physiologically relevant type of metal cation being present in the liquid proton donor in at least a physiological concentration; and no sodium being preferably present in the liquid proton donor.
14. The composition according to any one of the claim 10, 12, or 13, or use according to any one of the claims 11 through 13, the composition further comprising a purging gas permeating the second compartment of the device according to any one of the claims 1 through 8.
15. The composition according to any one of the claims 10, 12 through 14, or use according to any one of the claims 11 through 14, the treatment comprising the following steps: providing a flow of aqueous liquid through the first compartment; providing a flow of the purging gas through the second compartment; providing a flow of the liquid proton donor through the second compartment.
Description
[0029] Preferred embodiment examples of the invention are described in more detail below using the attached drawings.
[0030]
[0031]
[0032]
[0033]
[0034] The first compartment 2 permeated by the aqueous liquid can comprise any arbitrary shape, for example a cylindrical shape as shown in
[0035] It is noted that the arrangement and location of the second compartment 3 and of the third compartment 4, as shown in
[0036]
[0037] The purging gas, typically comprising pure oxygen (O.sub.2) flows through the second compartment 3. The semipermeable membrane 5 is disposed between the first compartment 2 and the third compartment 3. Due to a concentration gradient between the first compartment 2 and the second compartment 3 with respect to carbon dioxide (CO.sub.2), the carbon dioxide physically bound in the blood 7 is released and diffuses across the semipermeable membrane 5 into the second compartment 3. In return, oxygen diffuses out of the purging gas, across the semipermeable membrane 5, into the blood liquid, and is received by the erythrocytes 7 therein. Said procedure is well known from typical ECMO applications and is sketched in the first marked region 8.
[0038] The carbon dioxide chemically bonded in the bicarbonate compounds is released from the bicarbonate compounds by means of the liquid proton donor permeating the third compartment 4. A cation exchange occurs through the membrane 6 permeable to ions disposed between the first compartment 2 and the third compartment 4, and said exchange is further sketched in the second marked region 9. Said procedure is also induced by a concentration gradient with respect to an exchange ion. In the embodiment example shown for oxygenation of blood, the exchange ion is sodium (Na.sup.+), the target exchange ion in the example shown. The sodium diffuses through the membrane 6 permeable to ions into the (low-sodium) third compartment 4. In return, hydrogen cations present in the liquid proton donor diffuse out of the third compartment 4 into the first compartment 2. The hydrogen cation bonds to the bicarbonate (HCO.sup.−.sub.3), whereby carbonic acid (H.sub.2CO.sub.3) is formed, but is unstable and ultimately relatively quickly decomposes into water (H.sub.2O) and carbon dioxide. The carbon dioxide molecule thus released crosses the semipermeable membrane 5 into the second compartment 3 in a manner analogous to the physically dissolved carbon dioxide molecules. The liquid proton donor in the third compartment 4 thereby serves for releasing the chemically bonded carbon dioxide, while the removing of the carbon dioxide thus released out of the blood liquid takes place, as previously, by means of the purging gas permeating the second compartment 3.
[0039] In general, there are many different possibilities for the design of the interaction space between the three substances, particularly for the spatial arrangement of the first lines 33 of the second compartment 3 and the second lines 43 of the third compartment 4 relative to each other and within the first compartment 2. Three fundamental embodiments are sketched in the
[0040] The embodiment sketched in
[0041] According to the arrangement of the compartments 2, 3, 4 relative to each other shown in
[0042] Finally, a further potential embodiment of the interaction space of the device is shown in